The aim of this study was to investigate the relationship between lipoprotein(a) [Lp(a)] and albumin concentrations in the serum of patients with acute phase response (APR). We have compared the Lp(a) concentrations and apolipoprotein [apo(a)] phenotypes of 40 controls with those of 40 APR patients with normoalbuminaemia and 40 APR patients with hypoalbuminaemia. We have also compared concentrations of haptoglobin (Hp) and ad-antitrypsin (AAT) containing a high sialic acid content, similar to Lp(a).
is inversely related to serum Lp(a) concentrations. 6 ,7 Serum Lp(a) concentrations are genetically determined. Apo(a) size polymorphism accounts for 42-69% of Lp(a) concentration variations among individuals.P Although Lp(a) concentrations are mainly determined genetically, they are also modulated by several factors such as end-stage renal disease (ESRD), hormones (thyroid hormone, growth hormone, sex. hormones), and acute phase status."-!3 It is reported in ESRD patients that serum Lp(a) concentration is inversely related to serum albumin concentration.lv" When ESRD patients with hypoalbuminaemia are infused with albumin, serum Lp(a) concentration falls in proportion to the increase in albumin concentration." These results suggest that albumin plays a key role in the modulation of serum Lp(a) concentrations in ESRD patients.
In a previous study, we reported that Lp(a) behaves like an acute phase reactant whose concentration increases more than twofold during an acute phase response (APR) compared with controls.!?
In this study, we investigated the relationship between Lp(a) and albumin concentrations in the serum of APR patients.
MATERIALS AND METHODS

Subjects
The APR patients were recruited from patients whose erythrocyte sedimentation rates (ESR) exceeded 50mm/h. We randomly selected two age-and sex-matched groups of APR patients meeting the ESR criterion: group I comprised 40 patients with serum albumin concentrations less than 33 giL (APR patients with hypoalbuminaemia); and group II comprised patients with serum albumin more than 38 giL (APR patients with normoalbuminaemia).
Group I included 20 patients with infections (including seven who also had a tumour), II post-operative patients (including three who also had a tumour), seven patients with tumours and two patients with other diseases. Among group II patients there were ten patients with infections (including one who also had a tumour), 20 postoperative patients (including three who also had a tumour), six patients with tumours and four patients with other diseases.
Forty age-and sex-matched control subjects were randomly selected from healthy blood donors without evidence of an acute inflammatory reaction. All in the control group were free of the clinical, biochemical or haematological manifestations of cardiovascular, hepatic, renal or endocrinological diseases. Among the controls, the male-to-female ratio was I :0'6, and mean (SD) age was 48·0 (9'5) years. For group I and group II patients the male-to-female ratios were both I :0'6, and the mean (SD) ages were 50·7 (10'9) and 50·2 (10'7) years, respectively. The mean albumin concentration for controls, group I and group II patients were 46·7 (4'6), 29·0 (3'4) and 41·6 (3·3) giL, respectively.
Specimens were used for the study after completion of all requested diagnostic testing, Ann cu« Biochem 1999: 36 in accordance with the policies of the Institutional Review Board of Asan Medical Center.
Analytical methods Serum Lp(a) was determined using a commercially available one-step sandwich 'Immunozym Lp(a)' kit (lmmuno AG, Vienna, Austria). The test procedures were performed according to the recommendations of the manufacturer. As the minimal detectable Lp(a) level was 0·01 g/L, any levels below that limit were recorded as 0·01 g/L, At a concentration of 0·236 g/L, the mean intra-assay coefficient of variation (CV) was 3·2%; at a concentration of 0·244 giL the inter-assay CV was 6·3%.
The separation of apo(a) isoforms was performed with a commercial 4-15% gradient PhastGel (Pharmacia Biotech, Uppsala, Sweden) and PhastSystem (Pharmacia Biotech). Immunodetection was performed using Lp(a) phenotype kit (Immuno AG). The procedure of apo(a) phenotyping was performed exactly as previously described.!" The apo(a) phenotypes are designated as F, B, Sl, S2, S3, S4 and S5; their respective numbers of kringle IV repeats are 11-13, 14-16, 17-19, 20-22, 23-25, 26-28 and 29-42. 19 Isoforms were interpreted by comparison with an apo(a) phenotype standard with known kringle IV numbers. The apo(a) phenotype standard consisted of B, S I, S3, S4 and S5 isoforms, whose kringle IV numbers were 14, 19,23,27 and 35 respectively.
ESR was measured using a modified Westergren method. a l-antitrypsin (AAT) and haptoglobin (Hp) concentrations were measured using a nephelometric method by Beckman Array 360 (Beckman Instruments Inc, Brea CA, USA).
ESR was measured immediately after collection and other analyses were carried out within 2 weeks. Samples were stored at -70°C.
Comparisons of more than two groups were done by one-way analysis of variance (ANOVA) test. The Chi-square test of association was performed to elucidate independent relationships between the variables.
RESULTS
Serum lipoprotein(a) concentrations
The mean (SD) serum Lp(a) concentration of the controls was 0·190 (0'142) g/L, with significant increases in group I [0'353 (0'268) g/L; P=0'005] and group II [0,362 (0'249) g/L; P= 0'003; see Table I ]. However, there was no difference in mean serum Lp(a) concentrations between groups I and II (P=0'984) (Fig. 1 ). No significant difference was found in the distributions of apo(a) phenotypes among the controls and patients in groups I and II (P = 0'183; see Table 2 ). showed significantly higher serum Hp concentrations compared with group II patients with normoalbuminaemia (P = 0'042).
DISCUSSION
Serum exl-antitrypsin and haptoglobin concentrations
The mean (SD) serum AAT concentration of the controls was 1·422 (0'219) g/l., with significant increases in group I [2'925 (0'951)g/L; P<O·OOlj and group II [2-494 (0'607)g/L; P<O'OOI; see Table 1 ]. Group I patients with hypoalbuminaemia showed significantly higher serum AAT concentrations compared with group II patients with normoalbuminaemia (P=0·012).
The mean (SD) serum Hp concentration of the controls was 0·956 (0-442) g/L, Compared with controls, Hp was significantly higher in group I [2,932 (1,346) ; P<O'OOlj and group II patients [2,330 (1,280) ; P<O·OOlj (see Table 1 ).
Group I patients with hypoalbuminaemia
In this study, the mean Lp(a) concentration of 80 APR patients arbitrarily defined as having an ESR over 50mm/h was 0·358 (0'257) g/L, which was significantly higher than the mean for 40 normal controls [0,190 (0'142) giL; P<O·OOI]. These findings confirmed our previous report that Lp(a) is an acute phase reactant."?
Yang et al. observed that the serum albumin level played a major role in the serum Lp(a) modulation of ESRD patients," and there was a significant inverse correlation between serum Lp(a) and albumin concentration.lv'? Although the exact mechanism of the increase of the serum Lp(a) concentration in ESRD patients and the role of albumin in this mechanism were not clearly defined, the increase in the serum Lp(a) concentration in ESRD patients was suspected to be due to a decrease in catabolism rather than an increase in synthesis.P We intended to investigate whether there was a similar relationship between serum Lp(a) and serum albumin concentration in APR patients. However, there was no significant difference of the serum Lp(a) concentrations between APR patients with hypoalbuminaemia and APR patients with normoalbuminaemia, nor was there any relationship between Lp(a) and albumin concentrations in the two groups (P=0·932). We assume that the mechanism of Lp(a) increase in the APR patients was different from that in the ESRD patients.
Although there was no difference in the serum concentration of Lp(a) between APR patients with hypoalburninaemia and those with normoalbuminaemia, there was a significant difference in the serum AAT and Hp concentrations. These findings could be explained by different kinetics of acute phase reactants. Maeda et al. 21 compared various acute phase reactants following acute myocardial infarction and surgery. The serum concentration of C-reactive protein (CRP) reached its peak level 2 to 3 days after surgery; AAT, 4 to 5 days; lXI-acid glycoprotein (AAG), 5 to 6 days; and Hp after 6 to 9 days. The serum concentration of Lp(a) in acute myocardial infarction patients reached a peak level after a mean (SD) of 10-4 (1'9) days and in post-operative patients after a mean of 6·5 (2'3) days after surgery.
The regulation of APR is mediated by a complex network of cytokines, including interferons, interleukins and numerous growth factors, but interleukin-6 (IL-6) is the key mediator of acute phase protein synthesis in the liver.F Most of the studies of APR modulation by IL-6 were done in vitro, but Banks et al. 23 observed 'in vivo' changes of acute phase proteins in cancer patients after subcutaneous injection of IL-6. They reported that the positively reacting acute phase proteins -serum amyloid A, CRP, AAG, ed-antichymotrypsin. Hp, AAT, fibrinogen, C3, C4 and caeruloplasmin -all increased following IL-6 injection. There was generally a dose-response relationship between the incremental change and the amount of IL-6 administered. Their study therefore showed that IL-6 was capable of causing in vivo changes in the majority of acute phase proteins.
IL-6 and some other cytokines, including tumour necrosis factor, suppress hepatic albu-min synthesis-? and many cytokines of the APR increase capillary permeability, allowing albumin to leak from the blood into the interstitial space.P' This mechanism may explain why AAT and Hp concentrations are higher in the APR patients with hypoalbuminaemia than in the APR patients with normoalbuminaemia.
Lp(a) contains about six times more sialic acid than LDL.! The acute phase proteins AAT, Hp and AAG contribute 102mg, 69mg and 92mg sialic acid per litre of serum, respectively.P There were several reports that serum Lp(a) concentrations change in parallel with other acute phase reactants with a high sialic acid content. In chronic alcohol abusers, Lp(a) concentration increased in parallel with H P and AA T after 3 weeks of alcohol withdrawal therapy" and during oestrogen treatment the levels of Lp(a), AAG and Hp decreased by 23%, 18% and 25%, respectively." Recently, Ramharack et al. 28 demonstrated that Lp(a) and apo(a) mRNA expression in primary monkey hepatocytes was increased by administration of physiological levels of IL-6.
From this information, it would seem that the increase of the acute phase reactants with high sialic acid is modulated by IL-6, and the synthesis of Lp(a) increases with a concurrent increase in other acute phase reactants.
In conclusion, Lp(a) is an acute phase reactant whose synthesis concurrently increases with other acute phase proteins, especially those with a high sialic acid content. Unlike the situation in ESRD patients, serum Lp(a) concentration in APR patients is not related to the serum albumin concentration.
